Psychosomatic Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gilles, M.
Right arrow Articles by Deuschle, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gilles, M.
Right arrow Articles by Deuschle, M.
Related Collections
Right arrow Diabetes

Antagonism of the Serotonin (5-HT)-2 Receptor and Insulin Sensitivity: Implications for Atypical Antipsychotics

Maria Gilles, MD, Annette Wilke, Daniel Kopf, MD, Annemarie Nonell, MD, Hendrik Lehnert, MD and Michael Deuschle, MD

From the Central Institute of Mental Health, Mannheim, Germany (M.G., A.W., D.K., A.N., M.D.); Department of Endocrinology and Metabolism, Otto-von-Guericke-University, Magdeburg, Germany (H.L.).



View larger version (30K):

[in a new window]
  		Figure 1. Insulin sensitivity in subjects being treated with placebo and ketanserin, respectively.

 




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Psychosomatic Society